Kishida, a Japanese prime ministerial candidate, is targeting income disparities; rival Takaichi launches an offer
The mixture of features of CanSinoBIO and Sinovac COVID induces a stronger response than the study of Sinovac alone.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/42OELJ7KMVN23IOUGKVN7KEUZ4.jpg "The Swiss will need COVID certificates to go to bars, restaurants")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LQFWGPLJJBMOJINEG2ZQBL52BE.jpg "Novavax is initiating an initial phase trial for the combined influenza / COVID-19 vaccine")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4ZNKPQ5YFFPGBAIG62EAKXIHIQ.jpg "Kishida, a Japanese prime ministerial candidate, is targeting income disparities; rival Takaichi launches an offer")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KVGRQ46YK5OVFCSIO4AEZGDJMU.jpg "Money, mimicry and mind control: Big Tech puts a brake on ethics against AI")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/DHG3EVXRJRK4VDMCOHSAEM4XIE.jpg "NSW reports from Australia increase COVID-19 cases; vaccinations are accelerating")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PF5724G7FFM33CM7PBLEFD5DKU.jpg "75% of American adults have taken at least one dose of COVID-19: CDC vaccine")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IWY5OB4JJVMMDPUABIAWRELDB4.jpg "AstraZeneca chief Soriot says do not rush unnecessarily to COVID-The Telegraph booster vaccines")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/R7H24DJUC5NY7DAOCIRGFEMZJY.jpg "The mixture of features of CanSinoBIO and Sinovac COVID induces a stronger response than the study of Sinovac alone.")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IKU7XRKOJBISBJIVYXUTCDRJTM.jpg "EXCLUSIVE Allianz under investigation in Germany on investment funds")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/P2BZTIXSHNKMFMVAEFAAWWAALQ.jpg "North Korea rises to the powerful presidency of the ruling party, KCNA")